RxDoctor Payments Data

Amanda Brandon, PA

Physician Assistant · Corbin, KYNPI 1023445277

Payments from drug & device makers

$1,955in general payments, 2019–2025

Across 110 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$489
  • AstraZeneca$236
  • Pfizer$213
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$191
  • AbbVie$153
  • Boehringer Ingelheim$130
  • plus $543 from 13 others

What the payments were for

  • Food & beverage$1,955100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,955 in reported general payments places this provider in the 75th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$48,792
Medicare patients
125
Services billed
649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan666$659,070
JardianceEmpagliflozin486$492,601
VerquvoVericiguat351$329,148
FarxigaDapagliflozin Propanediol227$230,678
EliquisApixaban228$199,956
XareltoRivaroxaban26$24,516
BrilintaTicagrelor22$14,112
LinzessLinaclotide14$11,602
KerendiaFinerenone11$8,264
Bumetanide433$8,259
Ranolazine ErRanolazine20$2,654
Potassium Chloride64$1,711
Dexlansoprazole DrDexlansoprazole12$1,343
Metoprolol Succinate284$1,273
Spironolactone309$945

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$73$659,070666 claims
Boehringer IngelheimJardiance$130$492,601486 claims
MerckVerquvo$489$329,148351 claims
AstraZenecaFarxiga, Brilinta$236$244,790249 claims
PfizerEliquis$213$199,956228 claims
AbbVieLinzess$153$11,60214 claims
BayerKerendia$54$8,26411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →